Amy McKee's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 33,540 Automatic Stock Option Grant done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 33,540 | 33,540 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 15,294 | 47,177 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 8.91 per share. | 29 May 2026 | 631 | 31,883 (0%) | 0% | 8.9 | 5,622 | Common Stock |
| Biocryst Pharma Inc | Amy E. McKee | Director | Sale of securities on an exchange or to another person at price $ 8.97 per share. | 18 May 2026 | 11,180 | 31,252 (0%) | 0% | 9.0 | 100,285 | Common Stock |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 8.75 per share. | 27 Feb 2026 | 642 | 42,432 (0%) | 0% | 8.8 | 5,618 | Common Stock |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 7.18 per share. | 28 Nov 2025 | 783 | 41,790 (0%) | 0% | 7.2 | 5,622 | Common Stock |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 8.31 per share. | 29 Aug 2025 | 676 | 41,007 (0%) | 0% | 8.3 | 5,618 | Common Stock |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,181 | 27,181 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 12,500 | 40,331 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Amy McKee | Director | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 24 Jun 2024 | 8,600 | 27,831 (0%) | 0% | 6.3 | 54,352 | Common Stock |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 49,933 | 49,933 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 6,820 | 36,431 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 39,072 | 39,072 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,745 | 29,611 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 30,022 | 30,022 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 12,866 | 12,866 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 53,333 | 53,333 | - | - | Non-Qualified Stock Option |